Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)

v3.24.1.u1
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Allowance for other receivables $ 6,000 $ 4,600
Allowance for credit loss and other $ 0 $ 0
Preferred stock, par value (in dollars per share) $ 25 $ 25
Preferred stock, shares authorized (in shares) 500,000 500,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.1 $ 0.1
Common stock, shares authorized (in shares) 160,000,000 160,000,000
Common stock, shares issued (in shares) 121,940,831 121,397,553
Common stock, shares outstanding (in shares) 103,455,525 104,346,233
Treasury stock, shares (in shares) 18,485,306 17,051,320
Trade Accounts Receivable [Member]    
Allowances for credit losses $ 800 $ 500
Accounts With Joint Venture Owners [Member]    
Allowances for credit losses $ 800 $ 800